Clinical Trials

13 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03598270 2024-08-30

ANITA

417 enrolled

Ovarian Neoplasms

NCT02996825 2024-04-02

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

44 enrolled

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT00657878 2023-11-13

MITO-8

Phase 3 Unknown

215 enrolled

Ovarian Neoplasms

NCT01802749 2023-03-24

MITO16MANGO2b

Phase 3 Unknown

406 enrolled

GastrointestinalGenitourinaryGynecologicThoracic

Ovarian Neoplasms

NCT05733000 2023-03-10

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Phase 2 Recruiting

94 enrolled

Adenocarcinoma of Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02608684 2022-03-23

PemCiGem

21 enrolled 16 charts

Ovarian Neoplasms

NCT04679064 2021-08-27

NItCHE-MITO33

Phase 3 Unknown

427 enrolled

Ovarian Neoplasms

NCT02903004 2021-08-25

MITO23

242 enrolled

Ovarian Neoplasms

NCT01610206 2021-02-25

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

148 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT00227721 2020-12-02

Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer

30 enrolled 7 charts

GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00390182 2020-03-18

GCC0319

Phase 1/2 Completed

38 enrolled 9 charts

Gastrointestinal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT00910000 2018-09-10

Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer

Phase 1/2 Terminated

15 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03539328 2018-05-29

MITO27

Phase 2 Unknown

138 enrolled

Ovarian Neoplasms

NCT01936974 2018-02-20

PGA

7 enrolled 1 chart

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00610740 2017-12-28

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

18 enrolled 8 charts

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00620295 2017-11-29

Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

17 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Uterine Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00006453 2015-12-23

Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00031954 2015-12-23

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

105 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01624493 2015-12-23

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Phase 1/2 Withdrawn

Ovarian Neoplasms

NCT00267696 2015-04-30

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

45 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01196559 2015-02-18

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

44 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00312650 2015-01-12

Doxil and Gemcitabine in Recurrent Ovarian Cancer

24 enrolled

Ovarian Neoplasms, Recurrence

NCT00928642 2014-10-21

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

8 enrolled 8 charts

Neoplasms, Ovarian Neoplasms

NCT00418093 2014-06-19

Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

19 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003449 2014-05-22

Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

35 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

20 enrolled 8 charts

Ovarian Neoplasms, Peritoneal Neoplasms

NCT01131039 2013-12-20

Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Phase 2 Withdrawn

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00014456 2013-08-28

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

35 enrolled

AIDS-related Kaposi sarcoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Stomach Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT01388621 2013-08-20

PROVE

Phase 2 Unknown

140 enrolled

Ovarian Neoplasms, Recurrence

NCT00583622 2013-05-21

Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients

13 enrolled 5 charts

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00004066 2013-03-07

Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma

CNSGenitourinaryGynecologic

82 enrolled

GynecologicSarcoma

Leiomyosarcoma, Ovarian Neoplasms, Sarcoma

NCT00551122 2013-01-23

GemTIP

Phase 1/2 Unknown

23 enrolled

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms, Central Nervous System Neoplasms, Seminoma, Endodermal Sinus Tumor

NCT00003358 2013-01-16

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

24 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01570582 2012-04-04

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Phase 2 Unknown

314 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00429559 2011-07-22

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Phase 1/2 Completed

31 enrolled

Neoplasms, Ovarian Neoplasms

NCT00217555 2010-09-21

Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00102414 2006-11-14

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

356 enrolled

Ovarian Neoplasms, Recurrence, Disease Progression

NCT00312988 2006-04-11

Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy

450 enrolled